Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer

This study identified a new biomarker called somatic copy number altered driver (SCNA) genes in hard-to-treat ovarian cancer. This is important as there are some similarities with lung cancer, and now these biomarkers can be used to tailor therapeutics for precision medicine and better outcomes. This study was supported by a Stand Up To Cancer‐LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Research Grant.